Streetwise Reports (03/30/2026)
Israeli co. Can-Fite BioPharma Ltd. (CANF:NYSEAmerican) teamed up with Vetbiolix to trial Piclidenoson for dogs, with Phase 2 results due Q3 2026. Yet, one analyst still rates the stock as a Hold. Read on to see why. Streetwise Reports (03/30/2026)
An activist investor, Elliott Investment Management, has taken a billion-dollar stake in AI powerhouse Synopsys Inc. (SNPS:NASDAQ). See why analysts see the company finding success in this explosive market. Contributed Opinion
Stephen McBride (03/30/2026)
Stephen McBride of RiskHedge talks about his strategy for buying in a tumultuous world. Streetwise Reports (03/30/2026)
Uranium Energy Corp. (UEC:NYSE AMERICAN) restarts Wyoming mine, pursues conversion facility, and scales U.S. production assets amid domestic uranium shortage. Streetwise Reports (03/30/2026)
Contango ORE Inc (CTGO:NYSEA) and Dolly Varden Silver Corp. (DV:TSX.V; DVS:NYSEA; DVQ:FSE) successfully complete what one expert calls a transformative merger.